ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 984,93
-0,99%
Dow Jones
37 903,29
0,23%
DAX
17 932,17
-1,10%
Brent Oil
84,005
0,56%
Bitcoin
57 487,62
-1,29%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Veru Inc (VERU)

  7. Veru Inc (VERU) Actualités

VERU Veru Inc

1,48
0,13 (9,63%)
02 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Veru Inc VERU NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,13 9,63% 1,48 01:57:12
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
1,38 1,35 1,49 1,49 1,35
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
01/5/202414:30GLOBEVeru to Report Fiscal 2024 Second Quarter Financial Results..
30/4/202414:30GLOBEVeru Enrolls First Patients in Phase 2b Clinical Trial of..
25/4/202414:30GLOBEVeru to Present at the American Association of Clinical..
01/4/202422:05GLOBEVeru Announces Date of 2024 Annual Meeting of Shareholders
22/3/202421:05GLOBEVeru Reschedules Annual Meeting of Shareholders
12/3/202413:00GLOBEVeru Announces the Appointment of Louis Aronne MD as Chief..
28/2/202401:15GLOBEVeru Announces Notification from Nasdaq Related to Delayed..
20/2/202414:30GLOBEVeru Announces New Scientific Advisory Board for its..
15/2/202422:49EDGAR2Form NT 10-Q - Notification of inability to timely file Form..
15/2/202422:06EDGAR2Form 8-K - Current report
14/2/202422:32EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08/2/202413:00EDGAR2Form 8-K - Current report
08/2/202412:30GLOBEVeru Reports Fiscal 2024 First Quarter Financial Highlights
06/2/202422:27EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
06/2/202414:30GLOBEVeru Announces FDA Clearance of IND Application to Initiate..
31/1/202414:30GLOBEVeru to Present at the Oppenheimer 34th Annual Healthcare..
26/1/202422:06EDGAR2Form 8-K - Current report
26/1/202415:02EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
26/1/202415:00EDGAR2Form DEF 14A - Other definitive proxy statements
25/1/202414:30GLOBEVeru to Report Fiscal 2024 First Quarter Financial Results..
08/1/202414:30GLOBEVeru Submits IND Application to FDA for the Development of..
26/12/202322:31EDGAR2Form SC 13G - Statement of acquisition of beneficial..
19/12/202314:30GLOBEVeru to Host Investor Call on January 4th, 2024 to Discuss..
18/12/202315:01EDGAR2Form 8-K - Current report
15/12/202322:04EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
14/12/202315:00GLOBEVeru Announces Pricing of Public Offering of Common Stock
13/12/202322:23EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
13/12/202322:06EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
13/12/202322:04EDGAR2Form 8-K - Current report
13/12/202322:01GLOBEVeru Announces Proposed Public Offering of Common Stock
08/12/202322:02EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08/12/202320:30EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
18/11/202300:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/11/202323:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/11/202323:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/11/202323:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/11/202322:54EDGAR2Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]:..
15/11/202322:50EDGAR2Form 8-K - Current report
04/10/202314:30GLOBEVeru Reports Muscle Data from 5 Clinical Studies of..
02/10/202323:23EDGAR2Form 8-K - Current report
28/9/202322:22EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
26/9/202314:30GLOBEVeru Reaches Agreement with FDA on New Phase 3 Clinical..
20/9/202314:30GLOBEVeru to Participate in Fireside Chat at the 2023 Cantor..
11/9/202313:00EDGAR2Form 8-K - Current report
11/9/202313:00GLOBEVeru Reports Clinical Data from the Discontinued ARTEST..
30/8/202314:30GLOBEVeru to Present at the H.C. Wainwright 25th Annual Global..
10/8/202318:53EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/202313:00EDGAR2Form 8-K - Current report
10/8/202312:30GLOBEVeru Reports Fiscal 2023 Third Quarter Financial Results
03/8/202314:30GLOBEVeru to Report Fiscal 2023 Third Quarter Financial Results..

Dernières Valeurs Consultées

NASDAQ
VERU
Veru
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés